AU2003200488A1 - Tablets and Granules for Treating Water - Google Patents
Tablets and Granules for Treating Water Download PDFInfo
- Publication number
- AU2003200488A1 AU2003200488A1 AU2003200488A AU2003200488A AU2003200488A1 AU 2003200488 A1 AU2003200488 A1 AU 2003200488A1 AU 2003200488 A AU2003200488 A AU 2003200488A AU 2003200488 A AU2003200488 A AU 2003200488A AU 2003200488 A1 AU2003200488 A1 AU 2003200488A1
- Authority
- AU
- Australia
- Prior art keywords
- tablets
- pool
- water
- tablet
- granules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
1
AUSTRALIA
Patents Act 1990 COMPLETE SPECIFICATION STANDARD PATENT
APPLICANT:
Dudley Mills Pty Ltd [ACN 088 404 120], and Innovez Pty Ltd, [ACN 008 594 367], 30 Hutchison Crescent, Kambah, ACT, 2902, and 83 Kambalda Crescent, Fisher, ACT, 2611 [respectively]
ADDRESS:
INVENTOR: MILLS, Dudley John INVENTION TITLE: TABLETS AND GRANULES FOR TREATING
WATER
ASSOCIATED PROVISIONAL APPLICATION: PS0570 Filed 18 February 2002 ADDRESS FOR SERVICE: Paul A Grant and Associates PO Box Fisher, ACT 2611 The following statement is a full description of this invention, including the best method of performing it known to us:- TITLE: Tablets and Granules for Treating Water TECHNICAL FIELD This invention relates to tablets and granules for treating water to mitigate both bacterial and algal growth. It is also concerned with methods of forming such tablets and granules and with methods of their use, as well as to the composition of the tablets and granules themselves. The tablets and granules of the invention may include other agents intended to effect secondary treatments, such as water clarification and/or the regulation of pH, scale or oils. Such agents are known in lo the art and are not disclosed herein.
The materials and methods of the invention are particularly applicable to the treatment of water in swimming pools, ponds, fountains, cooling towers and the like where water is circulated by pumps through filters and where bacterial and/or growth may pose a health hazard to humans or where algal growth is unsightly or is likely to impair the operation of filters, fountains, cooling towers and the like.
The term 'tablets' is used herein to generically encompass coherent solid, or compacted particulate, products of a variety of shapes and sizes that may be formed as sticks, blocks, balls, pucks, rods, tubes, small or large biscuits, hollow floats of various forms, etc.
The term 'granules' is used herein to generically encompass un-compacted particulate products of a variety of shapes and sizes that may be formed as grains.
BACKGROUND TO THE INVENTION Water treatment tablets and granules for the slow release of chlorine into swimming pools are well known in the art. The chlorine-releasing compounds are typically chlorinated cyanurates or calcium hypochlorite formulated to dissolve slowly and to release chlorine into the pool to control bacterial growth. Once dissolved, chlorinated cyanurates regulate the release of chlorine into the water so that it is not lost at an undue rate in sunshine or in the presence of metals such as copper and iron. The problem of excessive chlorine loss due to these factors with compounds such as calcium hypochlorite is well documented in the art.
In swimming pools, it is usual for water treatment tablets to be placed in an inlet screen prior to the filter or in eroders placed after the filter so that they will dissolve or break up over a period of time, releasing active agents contained therein into the flow of water into or out of the filter. Such inlet screens include skimmer boxes, lint baskets and the like. Placing tablets in the inlet screen or eroders ensures that the agents are dispersed and mixed in the pool by water discharged from the filter into the pool. Granular materials are, more commonly, cast over the surface of the swimming pool water so that they will dissolve or break up more quickly than the tablets.
Manufacturer's instructions for the use of chlorinating tablets and granules are generally designed to ensure that the concentration of available chlorine in the pool is maintained at between 0.6 and 3.0 ppm. At this concentration, chlorine is an effective sanitizer; that is, it is effective in controlling bacterial growth to levels that are relatively safe for humans.
However, at below about 5 ppm, chlorine is not considered to be effective in controlling algal growth in pools. Pool owners are therefore expected to keep algae at acceptable levels by normal pool maintenance; that is, by scrubbing algal film from the bottom and walls of the pool and regularly pumping, filtering and back-washing the algae to waste. When these maintenance tasks become burdensome, many pool owners add algaecide products (which are typically organic compounds, such as quaternary amines) to suppress algal growth. The algaecides cannot be effectively included in chlorinating pool tablets because of adverse reactions with chlorine (or other sanitizing compounds such as peroxysulphate). Whilst inorganic algaecides (usually silver or copper compounds, such as copper sulphate) are sometimes included in tablets containing chlorinated compounds and are generally immune from adverse chlorine reactions, they are not very effective and pool owners need to continue scrubbing and filtering to control algae, albeit at a marginally lower level of intensity. Moreover, silver and copper compounds can introduce problems like staining.
OBJECTIVE OF THE INVENTION Accordingly, it is an objective of the invention to provide tablets and granules, along with methods of use, that are better suited to the control of both bacterial and algal growth in water.
OUTLINE OF THE INVENTION From one aspect, the invention comprises a physically coherent tablet or granule for use in the treatment of water, comprising a physical mixture of a water-soluble sanitizing compound and a lanthanide compound (other than a phosphate), the tablet or granule being adapted to dissolve or disintegrate over time in water so that the sanitizing compound and the lanthanide compound will be released therefrom.
From another one aspect, the invention comprises a tablet or granule for use in the treatment of water, comprising: a water-soluble sanitizing compound, a lanthanide compound (other than a phosphate) and a solid or paste-like matrix, carrier or binder adapted to dissolve or disintegrate over time in water, the sanitizing compound and the lanthanide compound being dispersed within the matrix such that, upon dissolution or disintegration of the matrix, the sanitizing compound and the lanthanide compound will be released therefrom.
The lanthanide compound can be incorporated as fine sparingly-soluble particles, or it can be incorporated as a soluble lanthanide species that forms fine insoluble lanthanide-containing particles upon contact with pool water or upon contact with the filter media. When a tablet containing a soluble lanthanide compound (for example, lanthanum chloride) is placed in the inlet current of a pool filter, the fine lanthanide particles (for example, lanthanum carbonate and lanthanum phosphate) will form in the water enroute to the filter and in the filter itself so as to be retained therein. The matrix of the tablet or granules may include a flocculating or a gel-forming material capable of binding or agglomerating the fine lanthanide particles as they are released or form so that they are more efficiently retained in the filter. [See our prior Australian patent No. 675512.] The flocculating or gelforming material also serves to prevent the lanthanide particles from dispersing freely in the pool as the matrix disintegrates or dissolves, and thus avoiding the pool becoming cloudy.
If desired, a stabilizing agent such as cyanuric acid or one of its salts for the chlorine sanitizer may be included in the tablet, as taught in the art. However, a stabilizer will not generally be necessary when using a stabilized sanitizer such as a chlorinated cyanurate.
In our prior Australian patent No. 675512, we showed that problematic algal growth in swimming pools was closely related to phosphate concentration in the pool water, phosphate being an important nutrient for algae. We also showed that particulate lanthanides could be used to sequester phosphate from the pool water and so reduce the algae problem. Since phosphates are important nutrients for algae in the pool environment, the lack of phosphate nutrient limits algal growth and weakens the algae that are present, increasing their sensitivity to the mildly algaecidal activity of dilute sanitizers such as chlorine. Thus, the addition of a lanthanide to tablets or granules capable of maintaining recommended concentrations of chlorine in a pool can effect the control of both bacterial and algal growth in normal pools, provided the lanthanide is sufficient to hold pool phosphate concentrations below about 100 ppb. Furthermore, because of the weakened nutritional state of the algae in the pool, the addition of a mild copperbased algaecide to the tablet will have an enhanced impact on algae in the pool.
When a tablet formed in accordance with the invention dissolves or disintegrates in the current of water flowing to a filter (eg, the inlet screen or 'skimmer box' of a swimming pool), the dissolved sanitizer and stabilizer (if present) are drawn through the filter and discharged for mixture in the pool as normal. However, the particulate lanthanide material that is introduced into, or that forms in situ within, the filter is substantially retained in the filter bed so that, as water is circulated past such particles, phosphate is sequestered from the water. In due course, the lanthanide will be converted to the phosphate form and will be no longer active but, since the lanthanide phosphate will be particulate and substantially insoluble in pool water it will be retained in the filter. However, additional active lanthanide particles will keep being loaded into the filter as new tablets added to the inlet screen dissolve or disintegrate. From time to time, the filter will be backwashed in the normal manner and the exhausted lanthanide material in the filter will be removed.
From another aspect, the present invention comprises a method of treating pool water to mitigate both bacterial and algal growth therein, the method comprising the steps of: contacting a tablet or granule with the water to effect the dissolution and/or disintegration thereof to gradually release a lanthanide compound adapted to sequester dissolved phosphate from the pool water by the formation of sparingly soluble lanthanide phosphate to thereby mitigate algal growth through nutrient removal, and a soluble sanitizing compound having bactericidal properties to thereby mitigate bacterial growth within the pool water, and removing the lanthanum phosphate from the pool.
The tablet or granule may be contacted with the pool water by simply casting or placing it into the pool water or by retaining it within a screen, floating eroder, or the like container that is placed in contact with the pool water. Where a pool filter is used, it will be convenient to place the tablet or granule in the water current entering or leaving the filter so as to facilitate dissolution or disintegration of the tablet or granule. The sparingly soluble lanthanide phosphate formed then may be removed from the pool water by filtration. This will be facilitated if the tablet or granule is placed in the inlet screen of the filter. The use of sanitizers, such as calcium hypochlorite, that aid the formation of flocs containing the lanthanide phosphate will also facilitate the removal of the lanthanum phosphate particles by filtration.
Thus, from another aspect, the present invention comprises a method of treating water in a pool to mitigate both bacterial and algal growth, comprising the steps of: circulating the water through a filter to create an inwards water current from the pool into the filter, retaining within the inwards current a slow-release tablet containing a soluble sanitizer and a lanthanide compound (other than a phosphate) so that the tablet will dissolve and/or disintegrate to thereby release the sanitizer and the lanthanide compound into said current, the sanitizer being dissolved in the pool water and the lanthanide compound forming sparingly soluble lanthanum carbonate or lanthanum phosphate particles by reaction of that compound with carbonate or phosphate within the pool water, retaining the lanthanum particles within the filter while continuing to circulate pool water through the filter, and removing the lanthanum particles from the filter by backwashing.
It will be seen that, since the tablet and method of this invention effect bacterial and algal control through separate and different mechanisms, the opportunity to optimize each mechanism separately exists. Bacterial control is effected by maintaining the concentration of a dissolved bactericide in the pool water above some minimum level (eg, 1 ppm for chlorine), as is conventional. Algal control is effected by using a lanthanide compound to remove an essential algal nutrient from the water 'at leisure', not by attempting to maintain the instantaneous concentration of a dissolved algaecide in the water above some arbitrary level.
The addition of an excess of lanthanide to the pool filter has no adverse affect on the quality of the pool water or on the health of pool users, since such compounds are insoluble and not bioactive.
Sanitizers suitable for use in the tablets of the invention may be selected from chlorinating and brominating substances such as alkali metal and alkaline earth metal hypochlorites, substituted and un-substituted chlorinated hydantoins, substituted and un-substituted chlorinated isocyanurates and isocyanuric acids, substituted and un-substituted chlorinated glycolurils, substituted and unsubstituted chlorinated oxazolidinones and imidazolidinones and like chlorinated substances, Lanthanides suitable for use in the tablets of the invention may be selected from compounds of the cations of chemical elements yttrium, lanthanides (which include lanthanum and are also known as 'rare earths') and zirconium. The compounds of the chemical element lanthanum are preferred due to their low cost and relatively high geochemical abundance. The single oxidation state of La 3 in water at normal temperatures and pressures is also an important advantage. The compounds may include other cations such as alkali metal, alkaline earth, aluminium cations and the like. The preferred anions of the compounds are sulphate, chloride, hypochlorite, chlorite, chlorate, perchlorate, bromide, hypobromite, bromate, perbromate, borate, nitrate, hydroxide, bicarbonate and carbonate. The compound may contain mixtures of cations and anions and water.
For example, hydrated (sodium, lithium) aluminium lanthanum (hydroxycarbonate, chloride). Phosphate is preferably substantially absent for best initial phosphate sequestration. Other anions which complex strongly with the cations such as EDTA and the like are also preferably substantially absent as they reduce the rate and mass of phosphate sequestration. The use of soluble hydrated lanthanides like lanthanum sulphate together with a flocculating substance like aluminium chloride has the surprising benefit of reducing the dissolution rate of the tablets by forming a thin film of gel like material around to tablet.
Given that the optimal concentration of chlorine in pool water is about 1 ppm, that the sequestering of phosphate by lanthanides is approximately stoichiometric, and that phosphate concentrations in normal pools are seldom more than 500 ppb and optimally below 50 ppb I have found that ratios of between 20:1 and 1:1 chlorine to lanthanum in tablets to be optimal. Ratios closer to 10:1 in slowly dissolving tablets are preferred for well-maintained pools in which phosphate levels are below 100 ppb. Ratios closer to 1:1 in rapidly dissolving tablets are preferred in pools that have phosphate concentrations near or above about 1000 ppb. Generally, larger proportions of lanthanide compounds tend to result in more rapidly dissolving tablets.
The rate of tablet dissolution can also be controlled by the choice of appropriate chlorinating compounds, matrices or binders. The chlorinating compounds that are preferred are chlorinated isocyanuric acids; chlorinated hydantoins are less preferred. Matrices or binders suitable for use in the tablets of the invention include unchlorinated isocyanuric acids, fatty acids, glycolurils, hydantoins, aluminium hydroxide chloride or sulphate, borax or borates and soluble salts. If the chlorinating agent is chlorinated isocyanuric acids, a slightly acid hydrated mixture of aluminium chloride or sulphate and lanthanum chloride or sulphate is preferred as the matrix. If the chlorinating agent is a chlorinated hydantoin, the more neutral hydroxides, bicarbonates and carbonates are preferred. Addition of halogenated glycolurils and halogenated hydantoins will tend to slow the rate of dissolution. They contribute to the halogen assay of the product and prolong the active life of the halogens. Soaps are less preferred because they produce minor quantities of scum and fats in some waters.
The matrix may include various organic and in-organic clarifiers or floccing agents, the most preferred being aluminium chloride and aluminium sulphate.
These compounds are moderately effective phosphate sequesterants in their own right, where the concentration of phosphate in the pool water exceeds a few ppm.
However only impracticably large amounts of soluble or insoluble aluminium salts will reduce the concentration of phosphate to a few ppb as is desired to secure negligible algal growth. However, I have found that the aluminium salts have beneficial effects in maintaining the reactivity of the lanthanide cations towards phosphate and in flocculating the otherwise fine un-reacted and reacted lanthanide compounds.
If desired, protective compounds such as cyanuric acid may be added to the tablet and granule formulation to protect the dissolved chlorinating compound against too rapid break down and/or to extend the life of active chlorine in the pool water in sunny conditions. It will be appreciated that the expected rate of loss of active chlorine in the pool will influence the selected ratio of chlorine to lanthanide compounds in the tablets and granules. Thus, the ratio of sanitizer (eg chlorine) to lanthanum in a tablet can vary widely.
Tablets can be formed by compacting the selected mixture into the desired shape, baking it at an elevated temperature (usually below 100 0 C) until at least partial fusion occurs, then suddenly cooling the mixture to reduce the generation of large crystals in the tablet. In addition, pressing agents or lubricants, such as soaps or boric acid, can be added to assist initial compaction of the mixture.
The rate of dissolution of a pool tablet will, of course, depend upon the ratio of mass to surface area, as well as upon the nature of the matrix. Tablets with more stable slower release matrices will generally be of smaller size and can be added in larger numbers to the inlet screen. Also, by staging the addition of smaller tablets to maintain a given number eg, five visible in the inlet screen, a more uniform release of sanitizer and phosphate capture can be achieved. To achieve a more uniform release rate from large tablets, they can be given a layered construction where the solubility of the matrix varies.
It will be appreciated that use of the tablets and granules of this invention is not confined to swimming pools, but they are applicable to any confined water system that is exposed to sunlight and therefore likely to have problems with algal growth.
In many of these other systems, such as water cooling systems, storage tanks, grey-water treatment pools and the like, water clarity is not of great importance and filtration circuits may not be required. The tablets and methods of the invention are also applicable in or to such systems. That is, the tablets and granules of the invention can be simply added to a body of water and allowed to dissolve, with or without the use of stirrers or water circulation.
It is desirable that the tablets and granules disclosed herein be packaged so as to preclude the entry of moisture during storage, since moisture can result in the generation of gas. For example, where chlorinated sanitizers are employed, chlorine gas can be generated if the tablets or granules become moist. As it is often difficult to totally exclude moisture during the formation of the tablet or granules, it is also desirable to ensure that the package allows the egress of gas that may be generated in storage, even where the ingress of external moisture is excluded. The use of rigid canisters with ill-fitting lids that permit the egress of gas under pressure but restrict contact with surrounding air are known in the art, but do allow 'breathing' of the canister with changing barometric pressure and, there, the ingress of atmospheric moisture.
From another aspect, the present invention comprises packaged tablets or granules of the type disclosed herein, characterized in that they are enclosed by a flexible plastic membrane and in that one-way valve means are provided to permit the egress of gas under pressure from within the package but to prevent the ingress of atmospheric air into the package. A convenient package is a blister pack or a vacuum pack formed from polyethylene, PVC or other film that is substantially impermeable to air and moisture and is substantially inert to chlorine gas. A convenient valve is simply a hole formed in the film that is covered externally with a flap secured over the hole by pressure-sensitive adhesive or by electrostatic attraction, such that net positive internal gas pressure will be relieved by lifting of the flap and the lack of net positive internal gas pressure will permit re-closure of the flap. Of course, net negative internal gas pressure will normally ensure firm closure of the flap. Indeed, it is envisaged that tablets and granules can be packed in this way under partial vacuum. This has the advantage that atmospheric pressure will hold the contents rigid and reduce the likelihood of breakage or fragmentation during transport. Indeed, if the tablet product is not stored for significant lengths of time, it is likely that it will still be under some vacuum when opened for use.
EXAMPLES
1 Base Mixture A dry paste was formed by mixing the following components together at 800 C in the following proportions by weight: Sanitizer: chlorinated isocyanuric acid, 1,000 g, Lanthanide: lanthanum sulphate, 500 g, Matrix: aluminum sulphate, 75 g, 2 Tablets A die of 75 mm diameter and about 75 mm deep was employed. It was held at about 800 C and, prior to being loaded with the basic mix, was sprayed with the boric acid lubricant. It was then charged with 200 g of the basic paste mix, which was also held at about 800 C. A piston was then forced into the die under a load of 10 t to compress the mix in the die. The tablet thus formed was then ejected from the die and cooled with dry air to quickly reduce its temperature to ambient.
It was robust, being difficult to break by hand, approximately 25 mm long and had a diameter of 75 mm.
The tablets formed in this way were vacuum-packed in heat-sealed PVC film having a flap-valve. This is illustrated by Figures 1 and 2, which shows a singletablet package 10 comprising a heat-sealed envelope or capsule 12 formed from PVC film 12 that encloses a tablet 16 of the type disclosed in this example. A hole 18 is formed in about the center of the top of the capsule and is sealed by a flap that is attached along edge 22 by heat-sealing (or other suitable means) to film 12 so that it will normally cover hole 18. The flap other than edge 22 is made to adhere to film 12 in the vicinity of hole 18 by the use of pressure sensitive adhesive or by electrostatic attraction in a manner known in the art. I have found that a tablet that is vacuum-packaged in this way can be stored for up to three months before internal pressure is sufficient to open the valve. Thereafter, storage life of the tablet appears to be indefinite and at least in excess of one year.
Three of the above tablets were placed in the skimmer box of an 80,000 I swimming pool with the filter pump running, the temperature of the pool water being about 250 C, the chlorine concentration being about 0.5 ppm and the phosphate concentration being about 300 ppb. After about 8 hours of pumping and circulation, the pool chlorine concentration had risen to 1.5 ppm, and the phosphate concentration in the pool water was lowered to about 200 ppb. The tablet had reduced in weight to 80 g. For the purposes of the trial, the pool was not used for swimming during this period.
3 Granules The base of the die in the above example was replaced with one having 24 mm diameter holes. The die was charged as before and the piston loaded to extrude lengths of the mixture, which were air dried at ambient temperature before being tumbled and sieved to produce granules of about 2.5 mm diameter and 2.5 mm length. 200 g of these granules were then loaded into plastic tubes of about 30 mm diameter and 140 mm long, the ends of the tubes being heatsealed.
The granules formed as above described were used by cutting one end off a plastic tube and pouring the contents into the skimmer box of the pool so that all the granules were drawn immediately into the pool filter. This resulted in a sudden noticeable increase in chlorine concentration of about 1.5 ppm within the pool and least in excess of one year.
The second packaging example, shown in Figures 5 and 6, comprises a package having similar container 52 with a peripheral flange 54. Container 52 is filled with a cast or preformed tablet 56 and closed by a thin flexible membrane closure 58. Closure 58 can be lightly attached around flange 54 using a sealant grease or releasable adhesive. However, because of the danger of the closure being displaced during handling or transport, it is preferred to securely attach closure 58 to flange 54 by a permanent seal or seam, indicated at 60, which is not complete but has a narrow vent gap 62. To assist sealing of the closure against air ingress, a sealant grease or releasable adhesive, indicated at 64, is applied between the flange 54 and closure 58 outward of and in the vicinity of gap 62.
a gradual reduction in phosphate concentration of about 120 ppb over a period of 8 hours.
3 Two-Component Tablet The base mixture of Example 1 was made, except that the aluminum sulphate was matrix was omitted. This mixture was heated to 100 0 C and compressed into a tablet as in Example 2 under a force of 12 t. The resultant tablet was ejected and cooled by dry air to ambient temperature, whereupon it was immediately sealed in a blister pack under a dry nitrogen atmosphere to ensure the exclusion of additional oxygen and moisture.
Tablets of Example 4 were used in exactly the same manner as those of Example 2. However, they were found to disintegrate at rate that was about 30% higher than the tablets of Example 2.
4 Packagqingq The packaging of the above-described tablets or granules will now be described with reference to the accompanying drawings, in which Figures 1 4 illustrate a first example of a suitable package and Figures 5 6 illustrate a second example.
The package 10 of the first example comprises a cup-like container 12 having a peripheral radial flange 14 to which a closure membrane 16 is secured by a heatseal seam 18. A hole 20 is formed in the center of closure 16 and is covered by a flexible flap 22, which is attached to closure 16 by a heal-seal seam 24 along one edge. If desired, flap 22 may be releasably adhered to the outside of closure 16 by the use of a grease-like sealing-aid or a releasable adhesive, indicated at 26.
The components of the package can be formed from PVC. If desired, the package may be sealed under partial vacuum, as is known in the packaging art.
In this example, a tablet 28 formed as above described is shown located in container 12.
It has been found that a dry tablet (or equivalent loose granules) packaged in this way can be stored for up to three months before internal pressure is sufficient to lift flap 22. Thereafter, storage life of the tablet appears to be indefinite and at
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003200488A AU2003200488A1 (en) | 2002-02-18 | 2003-02-13 | Tablets and Granules for Treating Water |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPS0570A AUPS057002A0 (en) | 2002-02-18 | 2002-02-18 | Tablets and granules for treating swimming pool water |
AUPS0570 | 2002-02-18 | ||
AU2003200488A AU2003200488A1 (en) | 2002-02-18 | 2003-02-13 | Tablets and Granules for Treating Water |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003200488A1 true AU2003200488A1 (en) | 2003-09-04 |
AU2003200488A8 AU2003200488A8 (en) | 2010-04-29 |
Family
ID=34063895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003200488A Abandoned AU2003200488A1 (en) | 2002-02-18 | 2003-02-13 | Tablets and Granules for Treating Water |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2003200488A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006202022A1 (en) * | 2005-05-26 | 2006-12-14 | Dudley Mills Pty Ltd | Means for loading swimming pool filters |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3488420A (en) * | 1967-03-13 | 1970-01-06 | Fmc Corp | Controlled solubility sanitizer tablet |
US4876003A (en) * | 1988-05-09 | 1989-10-24 | Olin Corporation | Encased pool chemical tablet with domed ends |
US5164109A (en) * | 1990-05-31 | 1992-11-17 | Olin Corporation | Algicidally enhanced calcium hypochlorite compositions |
-
2003
- 2003-02-13 AU AU2003200488A patent/AU2003200488A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006202022A1 (en) * | 2005-05-26 | 2006-12-14 | Dudley Mills Pty Ltd | Means for loading swimming pool filters |
Also Published As
Publication number | Publication date |
---|---|
AU2003200488A8 (en) | 2010-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20030156981A1 (en) | Tablets and granules for treating water | |
US8088417B2 (en) | Chlorine dioxide gel and associated methods | |
ZA200502875B (en) | Active bromide containing biocidal compositions and their preparation. | |
CA2683081C (en) | Calcium hypochlorite compositions comprising zinc salts and lime | |
US7993545B2 (en) | Tablet composition for the in-situ generation of chlorine dioxide for use in antimicrobial applications | |
US20090317486A1 (en) | Weekly floater pool sanitizer | |
US20100183693A1 (en) | Slow dissolving tablet composition for the in-situ generation of chlorine dioxide for use in a multi-tablet dispenser | |
US8017032B2 (en) | Tablet composition for the in-situ generation of chlorine dioxide for use in antimicrobial applications | |
AU781655B2 (en) | Stable, high available halogen 1,3,5-triazine-2,4,6-trione compositions having rapid dissolution rates | |
US20100136112A1 (en) | Oxidizing composition including a gel layer | |
US6022480A (en) | Methods and devices for treating water | |
AU2003200488A1 (en) | Tablets and Granules for Treating Water | |
JPH11505245A (en) | Chloroisocyanuric acid composition with reduced gas generation | |
EP0844215A2 (en) | Water-bath sanitising | |
EP3470379B1 (en) | Water-soluble capsule containing a solution with a treatment agent for treating swimming pool waters | |
US5352841A (en) | Agent for dosing aqueous systems with acrolein, processes for making same, and method of treating an aqueous system | |
JP2535975B2 (en) | Molding composition for water treatment | |
AU2003246045A1 (en) | Compression molded product of quick-dissolving chlorinated isocyanuric acid | |
EP0246062A2 (en) | Improvements in or relating to chlorination of water | |
CA2246519C (en) | Methods and devices for treating water | |
JPS63215601A (en) | Water-soluble granular antiseptic | |
JPH0368493A (en) | Method for purifying water |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |